Histone deacetylase inhibition as a mechanism for the therapeutic effect of statins (3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors) in follicular lymphoma

MeSH terms

• Antibodies, Monoclonal / pharmacology*
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents / antagonists & inhibitors
• Antineoplastic Agents / pharmacology*
• Antineoplastic Agents / therapeutic use
• Clinical Trials as Topic
• Depsipeptides / pharmacology
• Disease-Free Survival
• Drug Interactions
• Histone Deacetylase Inhibitors / pharmacology*
• Humans
• Hydroxamic Acids / pharmacology
• Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
• Lymphoma, Follicular / drug therapy*
• Lymphoma, Follicular / metabolism
• Lymphoma, Non-Hodgkin / drug therapy
• Rituximab
• Vorinostat